Hospital healthcare chain Sukino has raised $31 million in a Series B funding round led by Bessemer Venture Partners, with participation from existing investor Rainmatter. The fresh infusion of capital is set to strengthen Sukino’s presence in the rapidly growing post-acute and rehabilitative care segment, as the company looks to expand its footprint across multiple new geographies in India.

Key Highlights

• Sukino raises $31 Mn in Series B funding led by Bessemer Venture Partners.
• Funding will support expansion of Sukino’s healthcare services and technology platform.

Founded in 2016 by Rajinish Menon and Shalini Menon, Sukino operates at the intersection of hospital care and home recovery, offering structured rehabilitation services outside traditional acute hospital settings. The company focuses on delivering clinically supervised recovery solutions that help patients transition safely from hospital discharge to full functional independence. While Sukino primarily caters to stroke patients, its services also extend to neurological, orthopaedic, and oncology rehabilitation, addressing a broad range of complex recovery needs.

Currently, Sukino operates more than 850 beds across 11 centres located in Bengaluru, Kochi, and Coimbatore. The company has achieved group-level profitability, underscoring the sustainability of its care model. Over the past year, Sukino added five new centres and reported a robust 64% year-on-year growth, reflecting rising demand for organised rehabilitation care.

Also Read: Spector.ai Raises Rs 58 Crore Backed by IvyCap Ventures

Looking ahead, Sukino plans to significantly scale its operations by adding 22 additional centres over the next two years. This expansion strategy is supported by two key structural shifts in the healthcare ecosystem. First, insurance providers are increasingly covering rehabilitation care for 60 to 90 days, making such services more accessible to patients. Second, Indian families are showing growing acceptance of institutional recovery care, recognising its role in improving outcomes and reducing long-term complications.

With strong investor backing and favourable market dynamics, Sukino aims to play a larger role in shaping India’s post-acute healthcare landscape.